Positive context积极背景
Stocks股票 / Health Care / BMRN
BioMarin Pharmaceutical · Health Care
BMRN US listed · USD美股 · 美元
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.BioMarin Pharmaceutical Inc.是一家美国生物技术公司，总部位于加利福尼亚州圣拉斐尔。
Large cap大盘 · $13B
Health Care
S&P 400标普400中盘
Broken growth成长受损
$68.53
-$1.71 · -2.43%
52w low52周低 $48.79high高 $71.34
Extended — wait for a pullback过度拉伸 — 等待回撤
The low is already in and price has run. Wait for a pullback; hold if you're long.低点已经形成、价格已经拉升。等待回调再入场；若已持有可继续持有。
Live实时
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-08-14
Momentum (RSI 14)动量（RSI 14）
71
Overbought超买区域
vs 50-day average相对50日均线
+15.6% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+20.7% above上方
Long trend up长期向上
Volatility波动率
82th percentile第82百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
Estimates being cut预期下调
Mixed — beat 2 of last 4 quarters表现不稳 — 近 4 季中 2 季超预期
Post-earnings drift: -4.5% (20d)财报后漂移：-4.5%（20日）
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 55.2%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | BMRN | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 37.77x | 30.88 | |
| P/B市净率 | 2.16x | 3.54 | |
| P/S市销率 | 4.09x | 3.20 | |
| Earnings yield盈利收益率 | 2.65% | 2.51 | |
| FCF yield自由现金流收益率 | 5.50% | 4.00 | |
| EV/EBITDA企业价值/EBITDA | 24.27x | 19.05 | |
| P/FCF市值/自由现金流 | 18.18x | 22.49 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$3.2B2025
20202025
5-yr growth5年复合增速 11.6%
Earnings per share每股收益
$1.802025
20202025
5-yr growth5年复合增速 -16.9%
Free cash flow自由现金流
$725.0M2025
20202025
Operating margin营业利润率
12.7%
Net margin净利率
10.8%
FCF margin自由现金流利润率
25.7%
Balance-sheet quality财务体质 4/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 6%
Watch关注
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-2.68
Current ratio流动比率5.21
Capital allocation资本配置
Stock-based comp股权薪酬$181.4M
Share count change (1y)股数变化（1年）+0.8%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed -12.7%空头仓位变动 -12.7%
Technical技术面
BMRN made a new 52-week highBMRN 创52周新高
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$3.1M net (0 buyers, 3 sellers)-$3.1M 净值（0 买家，3 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Adding加仓 | 1.1% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~16 day(s) ago @ 58.4) and overbought (daily RSI 71). A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy止盈。日线筑底形态确实已经触发（摆动低点出现、动量转向上行），但为时已晚——价格已显著高于周期低点（约 16 天前形成 @ 58.4）且已超买（日线 RSI 71）。动量交叉属于滞后确认：在垂直拉升之后，只有当走势已经成熟时才会触发，因此筑底入场早已错过。这是追高，而非新的买入
Aug 10, 2026
BMRN made a new 52-week highBMRN 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $68.88.价格创出52周新高 — 全市场关注的动量/趋势极值。$68.88。
Aug 10, 2026
BMRN RSI reached overboughtBMRN RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $68.88.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$68.88。
Aug 7, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Aug 7, 2026
BMRN took relative-strength leadershipBMRN 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $63.81.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$63.81。
Aug 7, 2026
BMRN daily MACD crossed upBMRN 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $63.81.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$63.81。
Jul 31, 2026
BMRN daily MACD crossed downBMRN 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $60.02.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$60.02。
Jul 30, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 28, 2026
BMRN daily MACD crossed upBMRN 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $62.07.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$62.07。
Jul 27, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 27, 2026
BMRN StochRSI turned up from oversoldBMRN StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $60.27.StochRSI重回20上方 — 下行动量趋缓的最早预警。$60.27。
Jul 24, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Showing the last 15 of显示最近15条，共 273 signals条信号
Company profile公司档案
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.BioMarin Pharmaceutical Inc.是一家美国生物技术公司，总部位于加利福尼亚州圣拉斐尔。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Above market高于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
- Receivables stretch
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 37.8× | 30.9× | 36% |
| Price / Book市净率 | 2.2× | 3.5× | 74% |
| Price / Sales市销率 | 4.1× | 3.2× | 38% |
| EV / EBITDAEV/EBITDA | 24.3× | 19.1× | 34% |
| Earnings yield盈利收益率 | 2.6% | 2.5% | 53% |
| Free-cash-flow yield自由现金流收益率 | 6.3% | 5.3% | 67% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
34/100 — middle of the pack居中
vs market, 3 months相对大盘（3个月）
82/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
61/100 — middle of the pack居中
vs market, 12 months相对大盘（12个月）
53/100 — middle of the pack居中
Rank in sector行业内排名
#120 / 172
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +11.5% | +1.2% |
| 1 Month近1月 | +16.9% | +3.5% |
| 3 Months近3月 | +32.3% | +5.2% |
| 6 Months近6月 | +14.5% | +14.4% |
| Year to date年初至今 | +15.3% | +14.2% |
| 1 Year近1年 | +17.5% | +21.6% |
| 3 Years近3年 | -24.1% | +79.7% |
Trading information交易信息
Beta vs market贝塔
0.38
Volatility rank波动率分位
82th pctile
Short interest空头占比
6.5% of float
Market cap市值
$13B
EPS (trailing)每股收益
$1.81
Off 52-week high距52周高点
-2.4%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $1.9B | $1.8B | $2.1B | $2.4B | $2.9B | $3.2B |
| EPS每股收益 | $4.53 | $-0.35 | $0.75 | $0.87 | $2.21 | $1.80 |
| Free cash flow自由现金流 | $-29M | $209M | $55M | $63M | $487M | $725M |
| Gross margin毛利率 | 71.8% | 74.5% | 76.9% | 78.7% | 79.7% | 77.7% |
| Net margin净利率 | 46.2% | -3.5% | 6.8% | 6.9% | 15.0% | 10.8% |
| FCF margin自由现金流利润率 | -1.6% | 11.3% | 2.6% | 2.6% | 17.1% | 22.5% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$3.2B
Net income净利润
$349M
Operating cash flow经营现金流
$828M
Total assets总资产
$7.6B
Shareholder equity股东权益
$6.1B
Long-term debt长期负债
$597M
Shares outstanding总股本
0.19B
Returns & growth回报与增长
Return on equity股本回报率
5.7%
Return on assets资产回报率
4.6%
Debt / assets负债/资产
7.9%
Profit growth利润增速
-18.3%
Asset growth资产增速
+8.7%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: receivables +103% vs sales +73% — receivables outpacing sales, revenue-quality risk营运资本：应收 +103% 对销售 +73%——应收快于销售，营收质量风险
- Pricing power: gross margin +5.9pts over 6 years定价能力：毛利率 6 年上升 5.9 个百分点
- Capital discipline: share count +5.8% over 6 years (dilution)资本纪律：股本 6 年增加 5.8%（稀释）
- Balance sheet: Altman Z 6.38 — safe zone资产负债表：Altman Z 6.38——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
71
RSI (2-day)RSI（2日）
44
vs 20-day average相对20日均线
+10.4%
vs 50-day average相对50日均线
+15.6%
vs 200-day average相对200日均线
+20.7%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
expanding — range opening up扩张中 — 波幅放大
Range width percentile波幅宽度分位
97/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Mar 2026 | $0.58 | $0.78 | -25.6% |
| Dec 2025 | $0.28 | $0.07 | +300.0% |
| Sep 2025 | $-0.08 | $0.82 | -109.8% |
| Jun 2025 | $1.25 | $0.80 | +56.2% |
Estimate revisions预期修正
Analysts covering覆盖分析师
1
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
+2.3%
Net upgrades, 30 days净上调（30天）
-1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Adding增持 | 1.1% | $399M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
1 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': -43.8, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-15', 'available_on_first': '2023-11-15', 'holders_series': [2, 3, 3, 3, 2, 2, 2, 1, 1, 1, 1]}{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': -43.8, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-15', 'available_on_first': '2023-11-15', 'holders_series': [2, 3, 3, 3, 2, 2, 2, 1, 1, 1, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$3.1M
Insider buyers vs sellers内部人买家vs卖家
0 : 3
Short interest空头占流通盘
6.5%
Days to cover回补天数
7.4
Short interest change空头变化
-12.7%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Jul · 100%
Weakest month最弱月份
Jan · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 0% | -4.7% | 3 |
| Feb2月 | 67% | +9.0% | 3 |
| Mar3月 | 33% | -0.5% | 3 |
| Apr4月 | 0% | -7.2% | 3 |
| May5月 | 33% | -7.1% | 3 |
| Jun6月 | 67% | +0.3% | 3 |
| Jul7月 | 100% | +5.0% | 4 |
| Aug8月 | 100% | +8.4% | 4 |
| Sep9月 | 0% | -7.0% | 3 |
| Oct10月 | 0% | -6.3% | 3 |
| Nov11月 | 100% | +4.7% | 3 |
| Dec12月 | 67% | +6.0% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。